Chicago, IL – November 7, 2024 – Stocks in this week’s article are IAMGOLD IAG, Leidos Holdings LDOS, Brinker International EAT, Phibro Animal Health PAHC and State Street STT.
Investors generally consider a 52-week high a good criterion for an entry or exit point for a given stock. However, stocks touching new 52-week highs are often predisposed to profit-taking, resulting in pullbacks and trend reversals.
Moreover, given the high price, investors often wonder if the stock is overpriced. While the speculation is not absolutely baseless, all stocks hitting a 52-week high are not necessarily overpriced.
In fact, investors might lose out on top gainers in an attempt to avoid the steep prices.
Here, we discuss a strategy to find the right stocks. The technique borrows from the basics of momentum investing and bets on "buy high, sell higher."
Many times, stocks that hit a 52-week high fail to scale higher despite having potential. This is because investors fear that the stocks are overvalued and expect the price to crash.
Overvaluation is natural for most of these stocks as investors' focus (or willingness to pay the premium) has helped them reach the level. But that does not always indicate an impending decline. Factors such as robust sales, surging profit levels, earnings growth prospects and strategic acquisitions that encouraged investors to bet on these stocks could keep them motivated if there is no tangible negative. In other words, the momentum might continue.
Also, when a string of positive developments dominates the market, investors find their under-reaction unwarranted, even if there are no company-specific driving forces.
The ramp-up of the processing plant has been on track to exit the year at 90% of the design throughput rate of 36,000 tons per day. IAG is set to buy a 9.7% interest in Côté Gold, which will take its stake in the project to 70%.
IAG continues to invest in maximizing production and increasing the life of its existing mines, advancing development and exploration projects. Significant operational projects planned for the next years include the Westwood ramp-up to safely access other mining areas affected by the seismic activity in 2020. Plans include mill and plant upgrades, fleet and utilization improvements, tailings and surface water management optimization, and additional pit developments at Essakane. These projects are expected to reduce or control the company's cost structure and improve efficiency.
The Zacks Consensus Estimate for 2024 earnings has moved north by 8.2% to 53 cents per share in the past 30 days. IAG surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 200%. IAMGOLD has gained 110.3% in the year-to-date period.
Leidos Holdings is a global science and technology leader serving defense, intelligence, civil, and health markets. Its core capabilities include cybersecurity, data analytics, enterprise IT modernization, operations and logistics, sensors, software development and systems engineering. Its defense solutions continue to witness increased contract wins from the Pentagon and other U.S. allies, which led to a solid backlog of $40.56 billion at the end of September 2024. Such a solid backlog bolsters its revenue growth prospects.
Given the geopolitical hostility prevalent worldwide and the current U.S. administration's preference for more defense spending, the macroeconomic climate in the defense space has been favorable for Leidos Holdings' prospects. In light of this, it is important to note that the fiscal 2025 U.S. defense budget, which calls for $850 billion worth of investment, implies a 1% increase from the prior year's enacted amount. Such solid expenditure plans tend to improve the financial growth prospects of defense primes such as Leidos.
The Zacks Consensus Estimate for LDOS's 2024 earnings has moved north by 5.6% to $9.45 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 29.92%. Leidos Holdings has gained 75.6% in the year-to-date period.
Brinker International owns, operates, develops and franchises various restaurants under Chili's Grill & Bar (Chili's) and Maggiano's Little Italy (Maggiano's) brands. Chili's is a preeminent leader in the bar & grill category of casual dining. The brand has been functioning for over the last 40 years.
Brinker remains steadfast in its goal to drive traffic and revenues through a range of sales-building initiatives, such as streamlining of menu and its innovation, strengthening its value proposition, better food presentation, advertising campaigns, kitchen system optimization and introduction of better service platform. Brinker also intends to focus on balancing value offerings with margin expansion and adaptability to changing consumer preferences to drive growth.
The Zacks Consensus Estimate for EAT's fiscal 2025 earnings has moved north by 12.9% to $5.26 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in three of the trailing four quarters while missing once, the average surprise being 12.1%. Brinker International has gained 154.3% in the year-to-date period.
Phibro Animal Health is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for animal food, including poultry, swine, beef and dairy cattle and aquaculture.
Phibro's Animal Health business benefits from the introduction of high-value new products in the vaccine product line. The company has been strategically investing in vaccines, nutritional specialties and companion animals to capitalize on growth opportunities. With its extensive global presence, Phibro has a strong potential to expand into emerging markets. We expect the company's revenues to witness a 19% CAGR during fiscal 2025-2027. Further, a strong, supportive balance sheet is highly encouraging.
The Zacks Consensus Estimate for PAHC's fiscal 2025 earnings has moved north by 9% to $1.57 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in three of the trailing four quarters while missing once, the average surprise being 4.1%. Phibro Animal Health Corporation has gained 97.3% in the year-to-date period.
State Street Corporation is a financial holding company. It provides a range of products and services for institutional investors worldwide through its subsidiaries. The company primarily performs its business through its principal banking subsidiary, State Street Bank.
Solid business servicing wins, a global footprint and strategic buyouts will support its fee income. Our model estimates total fee revenues to record a CAGR of 3.3% by 2026. Rising assets under management (AUM) balance will support its financials. Our estimates for total AUM imply a CAGR of 7.3% by 2026.
The Zacks Consensus Estimate for STT's 2024 earnings has moved north by 2.6% to $8.38 per share in the past 30 days. The company surpassed the Zacks Consensus Estimate in the the trailing four quarters, the average surprise being 10.63%. State Street Corporation has gained 19.9% in the year-to-date period.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2364965/5-stocks-trading-near-52-week-high-with-more-upside-potential
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: [email protected]
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
State Street Corporation (STT) : Free Stock Analysis Report
Brinker International, Inc. (EAT) : Free Stock Analysis Report
Iamgold Corporation (IAG) : Free Stock Analysis Report
Leidos Holdings, Inc. (LDOS) : Free Stock Analysis Report
Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research